Clinical Trials Logo

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

NCT number NCT04488731
Other study ID # 2020-PHA-19
Secondary ID
Status Enrolling by invitation
Phase
First received
Last updated
Start date July 26, 2020
Est. completion date October 26, 2020

Study information

Verified date July 2020
Source Applied Science Private University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The effect of coffee and body weight during the last 3 months on the level of leptin, folic acid, and vitamin B12


Description:

Coffee consumption has been associated with several risk factors leading to cardiovascular diseases (CVDs), including hyperhomocysteinemia and hyperlipidemia. Frequent coffee consumption has beneficial effects in reducing the risk of diabetes mellitus (DM) type 2, obesity, liver disease, CVDs, some types of cancer, Parkinson's disease, and Alzheimer's disease. Controversies concerning coffee consumption benefits and risks in regards for CVDs were mentioned in many studies. Folic acid and vitamin B12 are necessary vitamins in homocysteine metabolism which is a risk factor for atherosclerosis. Leptin, is a hormone linked to obesity and it could be related to atherosclerosis.

The combined effect of coffee consumption and body weight on the levels of leptin, folic aid, and vitamin B12 is not well studied. In our study, we will study the effect of coffee consumption in males with different body mass indices to see the effect of several important parameters such as leptin, Folic acid, and vitamin B12.


Recruitment information / eligibility

Status Enrolling by invitation
Enrollment 120
Est. completion date October 26, 2020
Est. primary completion date September 26, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 26 Years
Eligibility Inclusion Criteria:

- male,

- ASU student,

- do not have any acute or chronic medical conditions.

Exclusion Criteria:

- students who used any medications for either an acute and/or a chronic condition during the past 3 months prior to the study entry.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Normal BMI and moderate coffee consumption
Normal BMI and moderate coffee consumption
Normal BMI and heavy coffee consumption
Normal BMI and heavy coffee consumption
overweight and moderate coffee consumption
overweight and moderate coffee consumption
overweight and heavy coffee consumption
overweight and heavy coffee consumption

Locations

Country Name City State
Jordan Applied Science University Amman

Sponsors (1)

Lead Sponsor Collaborator
Applied Science Private University

Country where clinical trial is conducted

Jordan, 

References & Publications (2)

Grubben MJ, Boers GH, Blom HJ, Broekhuizen R, de Jong R, van Rijt L, de Ruijter E, Swinkels DW, Nagengast FM, Katan MB. Unfiltered coffee increases plasma homocysteine concentrations in healthy volunteers: a randomized trial. Am J Clin Nutr. 2000 Feb;71(2 — View Citation

Ma Y, Peng D, Liu C, Huang C, Luo J. Serum high concentrations of homocysteine and low levels of folic acid and vitamin B(12) are significantly correlated with the categories of coronary artery diseases. BMC Cardiovasc Disord. 2017 Jan 21;17(1):37. doi: 1 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary leptin Plasma Concentration of leptin in ng /ml Baseline
Primary folic acid Plasma Concentration of folic acid in ng /ml Baseline
Primary Vitamin B12 Plasma Concentration of Vitamin B12 in pg /ml Baseline
Secondary fasting blood glucose Plasma Concentration of glucose mg/dL Baseline
Secondary lipid profile Plasma Concentration of LDL, HDL in mg/dl Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT05052918 - The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes N/A
Recruiting NCT04511234 - Sirolimus Coated Balloon Versus Standard Balloon for SFA and Popliteal Artery Disease N/A
Completed NCT05906797 - Impact of Non-surgical Periodontal Therapy in the Improvement of Early Endothelial Dysfunction in Subjects With Periodontitis. N/A
Completed NCT03273972 - INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers N/A
Suspended NCT02932176 - Machine Learning for Handheld Vascular Studies
Recruiting NCT05158257 - Clinical Of Plain Balloon Dilatation Combined Stent Versus Endovascular Debulking Combined Drug-coated Balloon to Treat Arteriosclerosis Occlusive Disease of Lower Extremity N/A
Completed NCT01212900 - Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression Phase 4
Completed NCT03697382 - Effect of Daily Steps on Fat Metabolism N/A
Recruiting NCT06230406 - T-Mem GEne in Atherosclerosis
Completed NCT03654313 - Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus Phase 1
Completed NCT00382564 - Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease N/A
Recruiting NCT02894931 - Effects of Dietary Interventions on Serum and Macrophage Atherogenicity N/A
Completed NCT02998918 - Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL N/A
Not yet recruiting NCT02578355 - National Plaque Registry and Database N/A
Recruiting NCT02265250 - Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
Completed NCT02268513 - Mediators of Atherosclerosis in South Asians Living in America (MASALA) Social Network Study
Completed NCT03393377 - Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination N/A
Completed NCT02224339 - New Technologies to Determine Carotid Plaque Vulnerability
Completed NCT02377310 - Pd/Pa vs iFRâ„¢ in an Unselected Population Referred for Invasive Angiography N/A
Completed NCT02116829 - Is There Room for Butter in a Healthy Diet? N/A